
A single subcutaneous dose led to a 4-point or greater itch reduction in 82% of patients with chronic pruritus at week 12 vs 22% with placebo, Attovia reported.
Miami, Fla. - Dermatologists who see diabetic patients with skin infections that have not responded to typical antibiotic treatment should suspect atypical mycobacteria, according to a case study by University of Miami researchers.






